These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 30708041)

  • 1. Prostate cancer-specific hallmarks of amino acids metabolism: Towards a paradigm of precision medicine.
    Strmiska V; Michalek P; Eckschlager T; Stiborova M; Adam V; Krizkova S; Heger Z
    Biochim Biophys Acta Rev Cancer; 2019 Apr; 1871(2):248-258. PubMed ID: 30708041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation of exposure to amino acids involved in sarcosine metabolic pathway on behavior of non-tumor and malignant prostatic cell lines.
    Heger Z; Gumulec J; Cernei N; Polanska H; Raudenska M; Masarik M; Eckschlager T; Stiborova M; Adam V; Kizek R
    Prostate; 2016 May; 76(7):679-90. PubMed ID: 26847870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual contribution of the mTOR pathway and of the metabolism of amino acids in prostate cancer.
    Schcolnik-Cabrera A; Juárez-López D
    Cell Oncol (Dordr); 2022 Oct; 45(5):831-859. PubMed ID: 36036882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid metabolism, amino acid metabolism, and prostate cancer: a crucial metabolic journey.
    Chen L; Xu YX; Wang YS; Zhou JL
    Asian J Androl; 2024 Mar; 26(2):123-134. PubMed ID: 38157428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serine, glycine and one‑carbon metabolism in cancer (Review).
    Pan S; Fan M; Liu Z; Li X; Wang H
    Int J Oncol; 2021 Feb; 58(2):158-170. PubMed ID: 33491748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer--a large nested case-control study within the JANUS cohort in Norway.
    de Vogel S; Ulvik A; Meyer K; Ueland PM; Nygård O; Vollset SE; Tell GS; Gregory JF; Tretli S; Bjørge T
    Int J Cancer; 2014 Jan; 134(1):197-206. PubMed ID: 23797698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precision medicine for advanced prostate cancer.
    Mullane SA; Van Allen EM
    Curr Opin Urol; 2016 May; 26(3):231-9. PubMed ID: 26909474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs.
    Schuster DM; Nanni C; Fanti S
    J Nucl Med; 2016 Oct; 57(Suppl 3):61S-66S. PubMed ID: 27694174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic targets for potential prostate cancer therapeutics.
    Twum-Ampofo J; Fu DX; Passaniti A; Hussain A; Siddiqui MM
    Curr Opin Oncol; 2016 May; 28(3):241-7. PubMed ID: 26907571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic and Amino Acid Alterations of the Tumor Microenvironment.
    Stepka P; Vsiansky V; Raudenska M; Gumulec J; Adam V; Masarik M
    Curr Med Chem; 2021; 28(7):1270-1289. PubMed ID: 32031065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of the mitochondrial amino acid pool in the sensitivity of erythroid cells to chloramphenicol: role of glycine and serine.
    Abou-Khalil S; Abou-Khalil WH; Whitney PL; Yunis AA
    Pharmacology; 1987; 35(6):308-16. PubMed ID: 3124141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.
    Wang Q; Tiffen J; Bailey CG; Lehman ML; Ritchie W; Fazli L; Metierre C; Feng YJ; Li E; Gleave M; Buchanan G; Nelson CC; Rasko JE; Holst J
    J Natl Cancer Inst; 2013 Oct; 105(19):1463-73. PubMed ID: 24052624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic signatures of malignant progression in prostate epithelial cells.
    Teahan O; Bevan CL; Waxman J; Keun HC
    Int J Biochem Cell Biol; 2011 Jul; 43(7):1002-9. PubMed ID: 20633696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Energy metabolism in cancer cells: how to explain the Warburg and Crabtree effects?
    Dell' Antone P
    Med Hypotheses; 2012 Sep; 79(3):388-92. PubMed ID: 22770870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Evaluation of
    Piert M; Shao X; Raffel D; Davenport MS; Montgomery J; Kunju LP; Hockley BG; Siddiqui J; Scott PJH; Chinnaiyan AM; Rajendiran T
    J Nucl Med; 2017 Aug; 58(8):1216-1223. PubMed ID: 28302759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic Alterations in Renal and Prostate Cancer.
    Ciccarese C; Santoni M; Massari F; Modena A; Piva F; Conti A; Mazzucchelli R; Cheng L; Lopez-Beltran A; Scarpelli M; Tortora G; Montironi R
    Curr Drug Metab; 2016; 17(2):150-5. PubMed ID: 26467063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic profiling for the identification of novel diagnostic markers in prostate cancer.
    Lucarelli G; Rutigliano M; Galleggiante V; Giglio A; Palazzo S; Ferro M; Simone C; Bettocchi C; Battaglia M; Ditonno P
    Expert Rev Mol Diagn; 2015; 15(9):1211-24. PubMed ID: 26174441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Androgen receptor and nutrient signaling pathways coordinate the demand for increased amino acid transport during prostate cancer progression.
    Wang Q; Bailey CG; Ng C; Tiffen J; Thoeng A; Minhas V; Lehman ML; Hendy SC; Buchanan G; Nelson CC; Rasko JE; Holst J
    Cancer Res; 2011 Dec; 71(24):7525-36. PubMed ID: 22007000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biosynthetic energy cost for amino acids decreases in cancer evolution.
    Zhang H; Wang Y; Li J; Chen H; He X; Zhang H; Liang H; Lu J
    Nat Commun; 2018 Oct; 9(1):4124. PubMed ID: 30297703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.